跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 960 条关于
“Capsida Biotherapeutics”
全部
960
临床试验
178
药物
215
机构
69
资讯
498
去年
CAP-003 Gene Therapy Shows Promise for Parkinson's Disease with GBA Mutations
去年
Capsida Biotherapeutics Advances Novel Gene Therapies for CNS Disorders Ahead of ASGCT 2025
去年
AbbVie Advances CNS Gene Therapy with Capsida Through $40 Million Option
去年
CAP-002 Receives FDA Orphan Drug Designation for STXBP1-Related Developmental and Epileptic Encephalopathy
去年
Capsida Suspends Gene Therapy Trial After First Patient Dies Following Treatment for Rare STXBP1 Disorder
去年
FDA Clears Capsida's Revolutionary IV Gene Therapy for STXBP1-DEE, First to Cross Blood-Brain Barrier
去年
CAP-002 Gene Therapy Receives FDA Orphan Drug Designation for STXBP1 Disorder
9个月前
Gene Therapy Trial Death Raises Safety Concerns for Brain-Targeted AAV Treatments
去年
Iovance Biotherapeutics Reports Strong Amtagvi Sales and Outlines Expansion Strategy
去年
Radiant Biotherapeutics Appoints Deborah Geraghty as President and CEO
第 1 页,共 50 页
上一页
下一页